已收盘 09-04 16:00:00 美东时间
+0.090
+0.09%
今日重点评级关注:BTIG:维持Kazia Therapeutics"买入"评级,目标价从34美元升至40美元;摩根大通:维持Annexon"超配"评级,目标价从10美元升至14美元
09-02 14:07
Wells Fargo analyst James Feldman maintains Camden Prop Trust (NYSE:CPT) with a Equal-Weight and lowers the price target from $113 to $110.
09-01 22:11
Camden Property ( ($CPT) ) has shared an update. On August 31, 2026, Camden Pro...
09-01 05:23
Barclays analyst Richard Hightower maintains Camden Prop Trust (NYSE:CPT) with a Equal-Weight and raises the price target from $122 to $123.
08-17 21:24
今日重点评级关注:古根海姆:维持Scynexis"买入"评级,目标价从24美元升至33美元;韦德布什:维持Kura Oncology"跑赢大市"评级,目标价从36美元升至38美元
08-14 11:51
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从49美元升至56美元;韦德布什:维持Zura Bio"跑赢大市"评级,目标价从15美元升至22美元
08-13 11:44
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24
Evercore ISI Group analyst Steve Sakwa maintains Camden Prop Trust (NYSE:CPT) with a In-Line and raises the price target from $113 to $114.
08-07 20:32
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
华盛资讯8月1日讯,卡姆登物业信托公布2026财年Q2业绩,公司Q2营收3.93亿美元,同比下降0.9%,归母净利润0.19亿美元,同比下滑76.7%。
08-01 00:48